Compare MHK & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MHK | LNTH |
|---|---|---|
| Founded | 1988 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 5.6B |
| IPO Year | 1995 | 2014 |
| Metric | MHK | LNTH |
|---|---|---|
| Price | $94.92 | $87.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $126.10 | $87.00 |
| AVG Volume (30 Days) | ★ 957.0K | 616.5K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.90 | ★ 3.41 |
| Revenue | N/A | ★ $343,374,000.00 |
| Revenue This Year | $3.38 | N/A |
| Revenue Next Year | $3.09 | $14.19 |
| P/E Ratio | $50.08 | ★ $25.60 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $93.60 | $47.27 |
| 52 Week High | $143.13 | $88.06 |
| Indicator | MHK | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 33.31 | 66.77 |
| Support Level | $94.86 | $72.35 |
| Resistance Level | $132.71 | N/A |
| Average True Range (ATR) | 4.28 | 2.40 |
| MACD | -0.74 | 0.15 |
| Stochastic Oscillator | 6.94 | 90.14 |
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Global Ceramic designs, manufactures, sources, distributes and markets a broad line of ceramic, porcelain and natural stone tile products used for floor and wall applications in residential and commercial channels for both remodeling and new construction. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.